Literature DB >> 15814679

Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock.

Hidekazu Shirota1, Ihsan Gursel, Mayda Gursel, Dennis M Klinman.   

Abstract

Endotoxic shock is a life-threatening condition caused by exposure to bacterial LPS. LPS triggers the release of acute phase, proinflammatory, and Th1 cytokines that facilitate the development of endotoxic shock. Synthetic oligodeoxynucleotides (ODN) expressing suppressive TTAGGG motifs effectively down-regulate the production of proinflammatory and Th1 cytokines elicited by a variety of immune stimuli. The current results demonstrate that suppressive ODN protect mice from LPS-induced endotoxic shock. Underlying this protective effect is the ability of suppressive ODN to bind to and prevent the phosphorylation of STAT1 and STAT4, thereby blocking the signaling cascade mediated by LPS-induced IFN-beta and IL-12. These findings suggest that suppressive ODN might be of use in the treatment of endotoxic shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814679     DOI: 10.4049/jimmunol.174.8.4579

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  DNA-Based Biomaterials for Immunoengineering.

Authors:  Midori Maeda; Taisuke Kojima; Yang Song; Shuichi Takayama
Journal:  Adv Healthc Mater       Date:  2018-12-05       Impact factor: 9.933

Review 2.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

3.  STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock.

Authors:  Daniela Herzig; Geping Fang; Tracy E Toliver-Kinsky; Yin Guo; Julia Bohannon; Edward R Sherwood
Journal:  Shock       Date:  2012-10       Impact factor: 3.454

4.  Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.

Authors:  Guang Yang; Min Wan; Yongsheng Zhang; Luguo Sun; Ran Sun; Dali Hu; Xiaojing Zhou; Li Wang; Xiuli Wu; Liying Wang; Yongli Yu
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

5.  Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians.

Authors:  Gianluca Storci; Sabrina De Carolis; Alessio Papi; Maria Giulia Bacalini; Noémie Gensous; Elena Marasco; Anna Tesei; Francesco Fabbri; Chiara Arienti; Michele Zanoni; Anna Sarnelli; Spartaco Santi; Fabiola Olivieri; Emanuela Mensà; Silvia Latini; Manuela Ferracin; Stefano Salvioli; Paolo Garagnani; Claudio Franceschi; Massimiliano Bonafè
Journal:  Cell Death Differ       Date:  2019-01-08       Impact factor: 15.828

Review 6.  Synthetic oligonucleotides as modulators of inflammation.

Authors:  Dennis Klinman; Hidekazu Shirota; Debra Tross; Takashi Sato; Sven Klaschik
Journal:  J Leukoc Biol       Date:  2008-04-22       Impact factor: 4.962

7.  Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis.

Authors:  Christian Bode; Takeshi Kinjo; W Gregory Alvord; Dennis M Klinman
Journal:  Carcinogenesis       Date:  2014-01-08       Impact factor: 4.944

8.  Therapeutic implications of orally delivered immunomodulatory oligonucleotides.

Authors:  Dennis M Klinman
Journal:  Mol Ther       Date:  2015-02       Impact factor: 11.454

9.  Suppressive oligodeoxynucleotides promote the generation of regulatory T cells by inhibiting STAT1 phosphorylation.

Authors:  Christian Bode; Jing Wang; Dennis M Klinman
Journal:  Int Immunopharmacol       Date:  2014-10-12       Impact factor: 4.932

Review 10.  Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.

Authors:  Petar S Lenert
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.